Quadrant Capital Group’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $725K | Sell |
5,617
-272
| -5% | -$39.1K | 0.02% | 720 |
|
|
2025
Q4 | $840K | Buy |
5,889
+6
| +0.1% | +$804 | 0.03% | 644 |
|
|
2025
Q3 | $706K | Sell |
5,883
-113
| -2% | -$14.3K | 0.02% | 683 |
|
|
2025
Q2 | $792K | Sell |
5,996
-139
| -2% | -$18.8K | 0.03% | 600 |
|
|
2025
Q1 | $852K | Buy |
6,135
+5,264
| +604% | +$817K | 0.03% | 446 |
|
|
2024
Q4 | $135K | Buy |
871
+1
| +0.1% | +$169 | 0.01% | 887 |
|
|
2024
Q3 | $159K | Buy |
870
+149
| +21% | +$22.1K | 0.01% | 816 |
|
|
2024
Q2 | $85.6K | Buy |
721
+10
| +1% | +$1.05K | 0.01% | 1097 |
|
|
2024
Q1 | $76.3K | Buy |
711
+117
| +20% | +$11.6K | 0.01% | 1147 |
|
|
2023
Q4 | $59.2K | Buy |
594
+518
| +682% | +$50.6K | 0.01% | 1293 |
|
|
2023
Q3 | $9.04K | Sell |
76
-87
| -53% | -$13K | ﹤0.01% | 2013 |
|
|
2023
Q2 | $29K | Buy |
163
+36
| +28% | +$6.61K | ﹤0.01% | 1529 |
|
|
2023
Q1 | $20.9K | Buy |
127
+12
| +10% | +$2.06K | ﹤0.01% | 1679 |
|
|
2022
Q4 | $18.1K | Sell |
115
-93
| -45% | -$14.2K | ﹤0.01% | 1702 |
|
|
2022
Q3 | $31K | Buy |
208
+141
| +210% | +$23.5K | ﹤0.01% | 1302 |
|
|
2022
Q2 | $11K | Sell |
67
-51
| -43% | -$9.82K | ﹤0.01% | 1606 |
|
|
2022
Q1 | $26K | Buy |
118
+53
| +82% | +$11.9K | ﹤0.01% | 1203 |
|
|
2021
Q4 | $15K | Sell |
65
-9
| -12% | -$2.1K | ﹤0.01% | 1437 |
|
|
2021
Q3 | $17K | Buy |
74
+5
| +7% | +$1.05K | ﹤0.01% | 1328 |
|
|
2021
Q2 | $14K | Sell |
69
-42
| -38% | -$8.64K | ﹤0.01% | 1388 |
|
|
2021
Q1 | $23K | Sell |
111
-30
| -21% | -$6.33K | ﹤0.01% | 1113 |
|
|
2020
Q4 | $30K | Sell |
141
-10
| -7% | -$1.94K | 0.01% | 933 |
|
|
2020
Q3 | $28K | Sell |
151
-36
| -19% | -$6.78K | 0.01% | 836 |
|
|
2020
Q2 | $34K | Sell |
187
-653
| -78% | -$130K | 0.01% | 863 |
|
|
2020
Q1 | $168K | Buy |
840
+52
| +7% | +$10K | 0.03% | 424 |
|
|
2019
Q4 | $142K | Buy |
788
+505
| +178% | +$86.9K | 0.02% | 804 |
|
|
2019
Q3 | $43K | Buy |
283
+264
| +1,389% | +$52.6K | 0.01% | 1286 |
|
|
2019
Q2 | $4K | Sell |
19
-211
| -92% | -$48.9K | ﹤0.01% | 2015 |
|
|
2019
Q1 | $53K | Buy |
230
+211
| +1,111% | +$50.6K | 0.01% | 1187 |
|
|
2018
Q4 | $4K | Hold |
19
| – | – | ﹤0.01% | 1712 |
|
|
2018
Q3 | $4K | Hold |
19
| – | – | ﹤0.01% | 1621 |
|
|
2018
Q2 | $4K | Hold |
19
| – | – | ﹤0.01% | 1635 |
|
|
2018
Q1 | $4K | Hold |
19
| – | – | ﹤0.01% | 1603 |
|
|
2017
Q4 | $3K | Hold |
19
| – | – | ﹤0.01% | 1656 |
|
|
2017
Q3 | $2K | Buy |
19
+10
| +111% | +$1.74K | ﹤0.01% | 1791 |
|
|
2017
Q2 | $0 | Hold |
9
| – | – | ﹤0.01% | 1941 |
|
|
2017
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 1808 |
|
|
2016
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 1710 |
|
|
2016
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 1692 |
|
|
2016
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 1664 |
|
|
2016
Q1 | $0 | Buy |
+9
| New | +$860 | ﹤0.01% | 1882 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Quadrant Capital Group's ICUI Position: Q1 2026 in Review
Quadrant Capital Group reduced its ICU Medical (ICUI) stake by 4.6% in Q1 2026, selling an estimated $39.1K and leaving 5,617 shares worth $725K. The position accounts for 0.02% of the portfolio, ranked #720.
Quadrant Capital Group first reported a position in ICUI in Q1 2016 and has held it in 41 quarters since. The position peaked at $852K in Q1 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Quadrant Capital Group held 5,617 shares of ICU Medical worth $725K as of Q1 2026.
- Quadrant Capital Group sold 272 ICU Medical shares in Q1 2026, an estimated $39.1K.
- ICU Medical made up 0.02% of Quadrant Capital Group's portfolio in Q1 2026, its #720 holding.
- Quadrant Capital Group first reported a position in ICU Medical in Q1 2016 and has held it in 41 quarters since.
- Quadrant Capital Group's ICU Medical position peaked at $852K in Q1 2025.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.